Cfbtm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Cfbtm1(KOMP)Wtsi |
Name: |
complement factor B; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4419769 |
Gene: |
Cfb Location: Chr17:35075350-35081492 bp, - strand Genetic Position: Chr17, 18.41 cM
|
Alliance: |
Cfbtm1(KOMP)Wtsi page
|
IMPC: |
Cfb gene page |
|
Mutant Cell Lines: |
EPD0403_5_A06, EPD0403_5_A07, EPD0403_5_B05, EPD0403_5_B06, EPD0403_5_B08, EPD0403_5_D05, EPD0403_5_D06, EPD0403_5_F06, EPD0403_5_H06 |
Germline Transmission: |
Earliest citation of germline transmission:
J:188991
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 3607 starting at position 35076626 and ending at position 35080233 of Chromosome 17 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
3 reference(s) |
|